Company News
Pharmaceutical Technology Europe
Two of the largest companies in the pharma industry are to join forces to supply and distribute 96-well Multi-SPE Extraction Plates. The instruments, which are to be circulated by Millipore, are manufactured by 3M for the purpose of isolating and concentrating low levels of analytes, and function by removing substances that interfere with mass spectrometry signal detection. The devices feature 3M Empore membranes, which produce clean extracts, extend LC-MS/MS column life and decrease instrument downtime.
Millipore and 3M Unite
Customers offered effective extraction and extended column life
Two of the largest companies in the pharma industry are to join forces to supply and distribute 96-well Multi-SPE Extraction Plates. The instruments, which are to be circulated by Millipore, are manufactured by 3M for the purpose of isolating and concentrating low levels of analytes, and function by removing substances that interfere with mass spectrometry signal detection. The devices feature 3M Empore membranes, which produce clean extracts, extend LC-MS/MS column life and decrease instrument downtime.
"SPE is a popular method for our customers, who need to focus on data quality at low detection limits. 3M technology is well-known for its performance, quality and reliability. The overall value is efficiency for high throughput sample processing," commented Jonathan DiVincenzo, VP of Millipore's marketing and R&D division
Simplified Access to Product Development
French company Groupe Novasep is to combine its process network with Rohm and Haas' advanced biosciences division. The strategic move, which gives Groupe Novasep direct access to customized separation media, and Rohm and Haas entry into advanced process development, including modelling and pilot-scale capabilities, should simplify access to a wide range of solutions by providing a single interface, as well as paving the way for the development of new products.
In Brief
Spooner Vicars Enters Pharma Arena
Owners of Spooner Vicars, a UK-based food equipment manufacturer, are planning to expand into the pharmaceutical packaging and processing market following its purchase by Avalanche Holdings. The deal, which took more than 2 years to complete, is hoped to grow Avalanche into a £200 million group within the next 3–5 years. Spooner Vicars' production lines are reported to enable manufacturers to innovate in the development of their product ranges, as well as minimize waste.
"We're innovators and it will be innovation, together with our highly-skilled workforce, that will drive the company forward," said Bruce Stimpson, joint owner of Avalanche Holdings. "We see a lot of opportunity to approach our market differently and we're very focussed as a team on new ways to push the business forward," he added.
In Brief
Single Software Solution
Agilent, a provider of instruments, supplies, software and services to the life science and chemical analysis industry, has added Scientific Software Inc. (SSI) to its portfolio. The acquisition, which should give Agilent a competitive position in the chromatographic data systems and informatics area, is planned to provide labs with the ability to work with just one software application that can handle applications and instruments from multiple vendors in a single, seamless and secure environment.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
